Filing Details

Accession Number:
0001209191-15-041137
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-11 16:30:39
Reporting Period:
2015-02-17
Filing Date:
2015-05-11
Accepted Time:
2015-05-11 16:30:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001316 Tg Therapeutics Inc. TGTX Pharmaceutical Preparations (2834) 363898269
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1377942 S.a.s.u. Biotechnologies Lfb 3, Avenue Des Tropiques
Bp 40305 Les Ulis
91942 Courtaboeuf Cedex I0
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-17 114,855 $6.53 5,114,855 No 4 P Direct
Common Stock Acquisiton 2015-05-07 2,500,000 $0.00 7,614,855 No 4 X Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 X Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants to Purchase Common Stock Disposition 2015-05-07 2,500,000 $0.00 2,500,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-11-09 No 4 X Direct
Footnotes
  1. The warrant became exercisable following equity financings in which TG Therapeutics, Inc. received gross proceeds of at least $7,500,000.